vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Lovesac Co (LOVE). Click either name above to swap in a different company.
Lovesac Co is the larger business by last-quarter revenue ($150.2M vs $83.5M, roughly 1.8× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs -7.0%, a 13.9% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 0.2%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-10.2M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
The Lovesac Company is an American furniture retailer, specializing in a patented modular furniture system called Sactionals. Sactionals consist of two combinable pieces, “Seats” and “Sides,” as well as custom-fit covers and associated accessories. Lovesac also sells Sacs, a bag seat filled with a proprietary foam mixture.
BLLN vs LOVE — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $150.2M |
| Net Profit | $5.7M | $-10.6M |
| Gross Margin | 69.9% | 56.1% |
| Operating Margin | 11.5% | -10.5% |
| Net Margin | 6.8% | -7.0% |
| Revenue YoY | 117.4% | 0.2% |
| Net Profit YoY | 138.3% | -114.0% |
| EPS (diluted) | $0.10 | $-0.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $150.2M | ||
| Q3 25 | $83.5M | $160.5M | ||
| Q2 25 | — | $138.4M | ||
| Q1 25 | — | $241.5M | ||
| Q4 24 | — | $149.9M | ||
| Q3 24 | $38.4M | $156.6M | ||
| Q2 24 | — | $132.6M | ||
| Q1 24 | — | $250.5M |
| Q4 25 | — | $-10.6M | ||
| Q3 25 | $5.7M | $-6.7M | ||
| Q2 25 | — | $-10.8M | ||
| Q1 25 | — | $35.3M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | $-14.9M | $-5.9M | ||
| Q2 24 | — | $-13.0M | ||
| Q1 24 | — | $31.0M |
| Q4 25 | — | 56.1% | ||
| Q3 25 | 69.9% | 56.4% | ||
| Q2 25 | — | 53.7% | ||
| Q1 25 | — | 60.4% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | 52.6% | 59.0% | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | 59.7% |
| Q4 25 | — | -10.5% | ||
| Q3 25 | 11.5% | -5.5% | ||
| Q2 25 | — | -10.8% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | -5.2% | ||
| Q3 24 | -32.9% | -5.3% | ||
| Q2 24 | — | -13.5% | ||
| Q1 24 | — | 16.1% |
| Q4 25 | — | -7.0% | ||
| Q3 25 | 6.8% | -4.1% | ||
| Q2 25 | — | -7.8% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | -3.3% | ||
| Q3 24 | -38.8% | -3.7% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | — | $-0.72 | ||
| Q3 25 | $0.10 | $-0.45 | ||
| Q2 25 | — | $-0.73 | ||
| Q1 25 | — | $2.22 | ||
| Q4 24 | — | $-0.32 | ||
| Q3 24 | $-1.47 | $-0.38 | ||
| Q2 24 | — | $-0.83 | ||
| Q1 24 | — | $1.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $23.7M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $189.3M |
| Total Assets | $327.5M | $495.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.7M | ||
| Q3 25 | $195.2M | $34.2M | ||
| Q2 25 | — | $26.9M | ||
| Q1 25 | — | $83.7M | ||
| Q4 24 | — | $61.7M | ||
| Q3 24 | — | $72.1M | ||
| Q2 24 | — | $72.4M | ||
| Q1 24 | — | $87.0M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $189.3M | ||
| Q3 25 | $-239.5M | $197.5M | ||
| Q2 25 | — | $201.2M | ||
| Q1 25 | — | $216.4M | ||
| Q4 24 | — | $196.5M | ||
| Q3 24 | $-242.9M | $202.1M | ||
| Q2 24 | — | $205.3M | ||
| Q1 24 | — | $217.5M |
| Q4 25 | — | $495.5M | ||
| Q3 25 | $327.5M | $493.7M | ||
| Q2 25 | — | $483.7M | ||
| Q1 25 | — | $532.3M | ||
| Q4 24 | — | $499.7M | ||
| Q3 24 | — | $481.1M | ||
| Q2 24 | — | $477.2M | ||
| Q1 24 | — | $482.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $-4.9M |
| Free Cash FlowOCF − Capex | $6.5M | $-10.2M |
| FCF MarginFCF / Revenue | 7.7% | -6.8% |
| Capex IntensityCapex / Revenue | 8.8% | 3.5% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-4.9M | ||
| Q3 25 | $13.8M | $12.2M | ||
| Q2 25 | — | $-41.4M | ||
| Q1 25 | — | $44.0M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $-7.0M | ||
| Q1 24 | — | $56.3M |
| Q4 25 | — | $-10.2M | ||
| Q3 25 | $6.5M | $7.8M | ||
| Q2 25 | — | $-50.0M | ||
| Q1 25 | — | $38.7M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | — | $119.0K | ||
| Q2 24 | — | $-14.3M | ||
| Q1 24 | — | $49.5M |
| Q4 25 | — | -6.8% | ||
| Q3 25 | 7.7% | 4.9% | ||
| Q2 25 | — | -36.1% | ||
| Q1 25 | — | 16.0% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | -10.8% | ||
| Q1 24 | — | 19.8% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | 8.8% | 2.7% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 5.5% | ||
| Q1 24 | — | 2.7% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
LOVE
| Showrooms | $102.7M | 68% |
| Internet | $37.3M | 25% |
| Other | $10.2M | 7% |
